Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 36 articles: HTML format

Single Articles

May 2024
1. AI L, Yi N, Qiu C, Huang W, et al
   Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review).
   Int J Oncol. 2024;64:46.
   PubMed     Abstract available
   
   
   April 2024
2. ZHANG W, Tang X, Peng Y, Xu Y, et al
   GBP2 enhances paclitaxel sensitivity in triple?negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway.
   Int J Oncol. 2024;64:34.
   PubMed     Abstract available
   
   
   
3. MBUGUA RW, Takano A, Tsevegjav B, Yokose T, et al
   Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer.
   Int J Oncol. 2024;64:43.
   PubMed     Abstract available
   
   
   March 2024
4. LI Z, Yu D, Li H, Lv Y, et al
   [Corrigendum] Long non?coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway.
   Int J Oncol. 2024;64:23.
   PubMed     Abstract available
   
   
   
5. HE Y, Ma Y, Zhu Y, Zhang J, et al
   HDAC inhibitors target IRS4 to enhance anti?AR therapy in AR?positive triple?negative breast cancer.
   Int J Oncol. 2024;64:25.
   PubMed     Abstract available
   
   
   
6. JIN Y, Zhao M, Xie Q, Zhang H, et al
   [Retracted] MicroRNA?338?3p functions as tumor suppressor in breast cancer by targeting SOX4.
   Int J Oncol. 2024;64:21.
   PubMed     Abstract available
   
   
   February 2024
7. LIU H, Li M, Lin Y, You H, et al
   Dual?directional effect of vinorelbine combined with cisplatin or fluorouracil on tumor growth and metastasis in metronomic chemotherapy in breast cancer.
   Int J Oncol. 2024;64:13.
   PubMed     Abstract available
   
   
   
8. WANG YY, Cheng KH, Hung AC, Lo S, et al
   Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis.
   Int J Oncol. 2024;64:12.
   PubMed     Abstract available
   
   
   December 2023
9. KAUSAR MA, Anwar S, El-Horany HE, Khan FH, et al
   Journey of CAR T?cells: Emphasising the concepts and advancements in breast cancer (Review).
   Int J Oncol. 2023;63:130.
   PubMed     Abstract available
   
   
   October 2023
10. SONG J, Tang Y, Song F
    Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation.
    Int J Oncol. 2023;63:111.
    PubMed     Abstract available
    
    
    September 2023
11. WANG M, Wu Y, Li X, Dai M, et al
    IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF‑kappaB signaling pathway.
    Int J Oncol. 2023;63:105.
    PubMed     Abstract available
    
    
    July 2023
12. WANG S, Huang M, Wang Z, Wang W, et al
    [Corrigendum] MicroRNA‑133b targets TGFbeta receptor I to inhibit TGF‑beta‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑beta/SMAD pathway in breast cancer.
    Int J Oncol. 2023;63:83.
    PubMed     Abstract available
    
    
    June 2023
13. JIN H, Ko YS, Yun SP, Park SW, et al
    P2Y(2)R‑mediated transactivation of VEGFR2 through Src phosphorylation is associated with ESM‑1 overexpression in radiotherapy‑resistant‑triple negative breast cancer cells.
    Int J Oncol. 2023;62:73.
    PubMed     Abstract available
    
    
    April 2023
14. XU L, Han F, Zhu L, Ding W, et al
    Advances in understanding the role and mechanisms of tumor stem cells in HER2-positive breast cancer treatment resistance (Review).
    Int J Oncol. 2023;62:48.
    PubMed     Abstract available
    
    
    March 2023
15. OKUI T, Hiasa M, Hasegawa K, Nakamura T, et al
    Lactate secreted via MCT4 from bone‑colonizing breast cancer excites sensory neurons via GPR81.
    Int J Oncol. 2023;62:39.
    PubMed     Abstract available
    
    
    February 2023
16. HAGAN ML, Mander S, Joseph C, McGrath M, et al
    Upregulation of the EGFR/MEK1/MAPK1/2 signaling axis as a mechanism of resistance to antiestrogen‑induced BimEL dependent apoptosis in ER(+) breast cancer cells.
    Int J Oncol. 2023;62:20.
    PubMed     Abstract available
    
    
    January 2023
17. ZHOU H, Gan M, Jin X, Dai M, et al
    [Corrigendum] miR382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumorassociated macrophages by targeting PGC1alpha.
    Int J Oncol. 2023;62.
    PubMed     Abstract available
    
    
    December 2022
18. WU H, Guo X, Jiao Y, Wu Z, et al
    TRIM35 ubiquitination regulates the expression of PKM2 tetramer and dimer and affects the malignant behaviour of breast cancer by regulating the Warburg effect.
    Int J Oncol. 2022;61.
    PubMed     Abstract available
    
    
    
19. ZHANG Y, Liang Y, Wang Y, Ye F, et al
    A novel ferroptosisrelated gene signature for overall survival prediction and immune infiltration in patients with breast cancer.
    Int J Oncol. 2022;61.
    PubMed     Abstract available
    
    
    
20. MENG Z, Zhang R, Wu X, Zhang M, et al
    PDL1 mediates triplenegative breast cancer evolution via the regulation of TAM/M2 polarization.
    Int J Oncol. 2022;61.
    PubMed     Abstract available
    
    
    October 2022
21. KATSUTA E, Gil-Moore M, Moore J, Yousif M, et al
    Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors.
    Int J Oncol. 2022;61.
    PubMed     Abstract available
    
    
    
22. ZHAO Y, Pang W, Yang N, Hao L, et al
    [Retracted] MicroRNA511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway.
    Int J Oncol. 2022;61.
    PubMed     Abstract available
    
    
    
23. ZHOU H, Gan M, Jin X, Dai M, et al
    miR382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumorassociated macrophages by targeting PGC1alpha.
    Int J Oncol. 2022;61.
    PubMed     Abstract available
    
    
    August 2022
24. DONG H, Wang W, Chen R, Zhang Y, et al
    [Retracted] Exosome-mediated transfer of lncRNASNHG14 promotes trastuzumab chemoresistance in breast cancer.
    Int J Oncol. 2022;61.
    PubMed     Abstract available
    
    
    
25. ZHANG X, Ge X, Jiang T, Yang R, et al
    Research progress on immunotherapy in triplenegative breast cancer (Review).
    Int J Oncol. 2022;61.
    PubMed     Abstract available
    
    
    May 2022
26. ZHAO L, Li Y, He M, Song Z, et al
    [Retracted] The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNKp53dependent mitochondrial apoptosis in breast cancer cells.
    Int J Oncol. 2022;60.
    PubMed     Abstract available
    
    
    
27. LAVORO A, Scalisi A, Candido S, Zanghi GN, et al
    Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
    Int J Oncol. 2022;60.
    PubMed     Abstract available
    
    
    April 2022
28. MENG Q, Zhou L, Liang H, Hu A, et al
    Spinespecific downregulation of LAPTM5 expression promotes the progression and spinal metastasis of estrogen receptorpositive breast cancer by activating glutaminedependent mTOR signaling.
    Int J Oncol. 2022;60.
    PubMed     Abstract available
    
    
    February 2022
29. BAKKER EY, Fujii M, Krstic-Demonacos M, Demonacos C, et al
    Protein disulfide isomerase A1associated pathways in the development of stratified breast cancer therapies.
    Int J Oncol. 2022;60.
    PubMed     Abstract available
    
    
    January 2022
30. LEE A, Jin HO, Masudul Haque M, Kim HY, et al
    Synergism of a novel MCL1 downregulator, acriflavine, with navitoclax (ABT263) in triplenegative breast cancer, lung adenocarcinoma and glioblastoma multiforme.
    Int J Oncol. 2022;60.
    PubMed     Abstract available
    
    
    
31. MAAROUF A, Boissard A, Henry C, Leman G, et al
    Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapyinduced senescence escape.
    Int J Oncol. 2022;60.
    PubMed     Abstract available
    
    
    November 2021
32. KITAYAMA K, Kawamoto T, Kawakami Y, Hara H, et al
    Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis.
    Int J Oncol. 2021;59.
    PubMed     Abstract available
    
    
    
33. VIETRI MT, D'Elia G, Benincasa G, Ferraro G, et al
    DNA methylation and breast cancer: A way forward (Review).
    Int J Oncol. 2021;59.
    PubMed     Abstract available
    
    
    March 2021
34. TAKENAGA K, Ochiya T, Endo H
    Inhibition of the invasion and metastasis of mammary carcinoma cells by NBD peptide targeting S100A4 via the suppression of the Sp1/MMP14 axis.
    Int J Oncol. 2021;58:397-408.
    PubMed     Abstract available
    
    
    
35. GUI C, Zhang C, Xiong X, Huang J, et al
    Total flavone extract from Ampelopsis megalophylla induces apoptosis in the MCF7 cell line.
    Int J Oncol. 2021;58:409-418.
    PubMed     Abstract available
    
    
    January 2021
36. LI J, Shi K, Xu T, Hu J, et al
    Mechanisms regulating DMTF1beta/gamma expression and their functional interplay with DMTF1alpha.
    Int J Oncol. 2021;58:20-32.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.